MedPath

Evaluation of Serum Interleukin 6 and 8 in Children With Acute Gastroenteritis

Conditions
Acute Gastroenteritis
Acute Diarrhea
Interventions
Diagnostic Test: Evaluation of serum levels of IL-6 and IL-8
Registration Number
NCT05213325
Lead Sponsor
Sohag University
Brief Summary

Cytokines, such as IL-6 and IL-8 can be used as markers of acute infections, including acute gastroenteritis. This study aims to evaluate serum levels of interleukins 6 and 8 in children with acute gastroenteritis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Children aged 6 months to 5 years.
  • Acute diarrhea: defined according to WHO criteria as the "passage of loose or watery stools at least three times in a 24 h period", lasts less than 14 days, with or without fever or vomiting, but considering the importance of change in stool consistency rather than frequency, and the usefulness of parental insight in deciding whether children have diarrhea or not.
Exclusion Criteria
  • Malnutrition or obesity
  • History of antibiotic therapy in the last 72 hours.
  • Acute diarrhea in association with systemic infections
  • Malignancy
  • Chronic diarrhea
  • Autoimmune and autoinflammatory diseases.
  • Chronic renal/liver failure
  • Diabetes mellitus

Group 2: Controls (Healthy control children)

Inclusion Criteria:

• Healthy children aged 6 months to 5 years.

Exclusion Criteria:

  • Acute diarrhea
  • Malnutrition or obesity
  • History of antibiotic therapy in the last 72 hours.
  • Acute diarrhea in association with systemic infections
  • Malignancy
  • Chronic diarrhea
  • Autoimmune and autoinflammatory diseases.
  • Chronic renal/liver failure
  • Diabetes mellitus

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CasesEvaluation of serum levels of IL-6 and IL-8Children with acute diarrhea
ControlEvaluation of serum levels of IL-6 and IL-8Healthy control children
Primary Outcome Measures
NameTimeMethod
Serum level of Interleukin 6Within the first 3 days of acute diarrhea

Difference in serum level of interleukin 6 between cases and control groups

Serum level of Interleukin 8Within the first 3 days of acute diarrhea

Difference in serum level of interleukin 8 between cases and control groups

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University Hospital

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath